Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01306149
Other study ID # FWO01-03-21
Secondary ID
Status Completed
Phase N/A
First received February 23, 2011
Last updated October 24, 2017
Start date July 2002
Est. completion date January 31, 2017

Study information

Verified date October 2017
Source Universitaire Ziekenhuizen Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aims of this study are

1. To evaluate the natural history of plasma concentrations and renal and peritoneal clearances of small water-soluble uremic retention molecules (URM), 'middle molecules', and protein bound URM in incident peritoneal dialysis (PD) patients.

2. To evaluate the natural history and determinants of the generation rate of URM originating from bacterial protein fermentation in PD patients.

3. To evaluate the natural history of biochemical parameters of mineral metabolism in incident PD patients.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date January 31, 2017
Est. primary completion date January 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Incident PD patients, defined as patients who started on PD as first renal replacement therapy less than 8 weeks before inclusion

- written informed consent

- age > 18 years old

Study Design


Related Conditions & MeSH terms

  • Complication of Peritoneal Dialysis

Locations

Country Name City State
Belgium University Hospital Leuven Vlaams-Brabant

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary natural history of clearances and serum parameters of mineral metabolism and protein-bound toxins To evaluate the natural history of plasma concentrations and renal and peritoneal clearances of small water-soluble uremic retention molecules (URM), 'middle molecules, and protein bound URM in incident peritoneal dialysis (PD) patients. 15 years
Secondary determinants of generation rate of uremic retention solutes To evaluate the natural history and determinants of the generation rate of URM originating from bacterial protein fermentation in PD patients. 15 years on average
See also
  Status Clinical Trial Phase
Completed NCT03286712 - The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients Phase 4